This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Jake Axford: Innovator in Pharmaceutical Chemistry
Introduction
Jake Axford is a notable inventor based in Boston, MA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating SMN-deficiency-related conditions. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Jake Axford holds a patent for "Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions." This invention provides a compound of Formula (X) or a pharmaceutically acceptable salt thereof. It also outlines a method for manufacturing these compounds and their therapeutic uses. Furthermore, the patent includes a combination of pharmacologically active agents and a pharmaceutical composition, highlighting the potential impact of his work on medical treatments.
Career Highlights
Jake Axford is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other talented professionals in the field. His career is marked by a commitment to innovation and a focus on developing solutions that address critical health issues.
Collaborations
Throughout his career, Jake has worked alongside notable colleagues, including Natalie Alysia Dales and Moo Je Sung. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Jake Axford is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments for SMN-deficiency-related conditions. His patent and collaborations reflect his commitment to innovation and improving patient outcomes.